Early Phase Trials Medical Oncologist / Translational Researcher 👩🏻⚕️ @kinghorncancer St Vincent’s Hospital Sydney Associate Professor @UNSW. MOGA Exec. #PrecisionMedicine #drugdevelopment
Passionate about mentorship ❤️ / wellness 🤸🏻♀️/ communication 🧬📣
Jia (Jenny) Liu MD PhD
Loading...
2011 PhD student → 2025 drug development oncologist.
A long road, a lot of growth, and so many people to thank along the way.
Grateful to be promoted to Conjoint Associate Professor at @UNSW.
Excited for the next stage of global collaboration in early phase trials 🧬🧫🔬👩🏻⚕️
Jia (Jenny) Liu MD PhD
One of the Most Insightful Sessions for Me at ESMO 2025 - Jia (Jenny) Liu
@jiajennyliu.bsky.social @myesmo.bsky.social
oncodaily.com/voices/jia-j...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMO #ESMO25 #ESMO2025
📢 ACORD 2026 applications are OPEN
6-day immersive workshop helping early-career clinical researchers turn strong ideas into high-quality, fundable clinical trials with expert mentorship!
🌏 Strongly encouraging applications from across the Asia-Pacific
📅 Sept 2026 Sydney
Congrats @RashaCosman on late breaking oral presentation, showcasing safety and MOA of novel in vivo CAR targeting TROP2 expressing tumors #SITC25 @NECTANSW - led trial from 🇦🇺 👏.
This technology will expand access to solid tumor cell therapy 🌟
Insights on ADC Toxicity Strategies in Drug Development from ESMO25 - Jia (Jenny) Liu
@jiajennyliu.bsky.social @ptarantinomd.bsky.social @myesmo.bsky.social
oncodaily.com/voices/adc-t...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMO #ESMO25 #ESMO2025
An incredible presentation - thank you @drcamidge.bsky.social for your courage, insight and inspiration as a patient and clinician who has walked both sides of the cancer journey
Must watch ⬇️
m.youtube.com/watch?v=cnh5...
🌏 Full circle moment — from developing my first trial protocol as a trainee at #ACORD19 to now being elected Deputy Convenor (2026) and incoming Chair of the 🇦🇺/APAC Oncology Research Workshop.
🙏 opportunity to train the next gen of clinical trialists
shorturl.at/RN44X
The TIGIT catastrophe‼️
30 agents
220 trials
~50,000 patients
>$3B+ invested
0 approvals.
This is herding in drug development.
In BMJ Oncol we examine why it happens, the hidden costs, and what needs to change.
It’s already happening again in ADCs...
🔗: t.co/dvbS49jGkF
Co-Chairing the Inaugural Tumour-Agnostic Track at ESMO25 - Jia (Jenny) Liu
@jiajennyliu.bsky.social @myesmo.bsky.social
oncodaily.com/voices/jia-l...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMO #ESMO25 #ESMO2025
Jia (Jenny) Liu: Insights on ADC Toxicity Strategies in Drug Development from ESMO25 / cancer, ESMO, ESMO 2025, ESMO 2025 Congress, ESMO2025, ESMO25, Jia
Jia (Jenny) Liu: One of the Most Insightful Sessions for Me at ESMO 2025 / cancer, ESMO, ESMO 2025, ESMO 2025 Congress, ESMO2025, ESMO25, Jean-Yves Blay, Jia
At last week’s lung cancer conference I went full public with my dual role as patient and expert. I spoke after Jane Perlmutter a four time survivor (middle). Both of us were introduced by Dr Shirish Gadgeel- Jane’s doctor and my friend.
